Sa'ar Yaniv

Stock Analyst

(n/a)
# 4,475
Out of 4,479 analysts
1
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

1 Stocks

Galectin Therapeutics
Oct 19, 2017
Initiates: Buy
Price Target: n/a
Current: $2.28
Upside: -